Quarterly Earnings Releases and Product Advancement Updates - Analyst Notes on Occidental, Monsanto, EOG, Anadarko and Marathon

NEW YORK, May 8, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Occidental Petroleum Corporation (NYSE: OXY), Monsanto Company (NYSE: MON), EOG Resources Inc. (NYSE: EOG), Anadarko Petroleum Corporation (NYSE: APC) and Marathon Petroleum Corp. (NYSE: MPC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2189-100free.

Occidental Petroleum Corporation Analyst Notes
On May 5, 2014, Occidental Petroleum Corporation (Occidental) released its Q1 2014 earnings results. The Company reported quarterly net sales of $6.1 billion, up 3.7% YoY. Helped by the higher prices of oil, NGL and gas in U.S., the Company stated that its net income during Q1 2014 increased to $1.39 billion, or $1.75 per diluted share, from $1.36 billion, or $1.68 per diluted share, in Q1 2013. On average, analysts polled by Reuters estimated the Company to report profit of $1.70 per share and revenue of $5.9 billion. For Q1 2014, daily oil and gas production volumes averaged 745,000 BOE, down from 763,000 BOE in Q1 2013, mainly due to reduced gas drilling in U.S. The full analyst notes on Occidental are available to download free of charge at:

http://www.analystsreview.com/2189-OXY-08May2014.pdf

Monsanto Company Analyst Notes
On May 1, 2014, Monsanto Company (Monsanto) announced that its insect forecasting tool at 'insectforecast.com,' which helps farmers to protect their crop from pests, is now equipped with capability to monitor soybean aphids, a pest that can significantly damage a crop and reduce yield if not dealt with effectively. With the addition of this new feature, the insect forecasting tool helps soybean farmers in managing the pests in their fields. In addition, the tool helps both corn and soybean farmers in understanding the current pest pressures and make more accurate predictions for the following year. "Now insectforecast.com is the single-stop source for finding out about the latest migration patterns and research for soybean aphids along with other key pests," says Tony White, Soybean Product Development Manager for Genuity, a Monsanto's brand. The full analyst notes on Monsanto are available to download free of charge at:

http://www.analystsreview.com/2189-MON-08May2014.pdf

EOG Resources Inc. Analyst Notes
On May 5, 2014, the shares of EOG Resources Inc. (EOG) moved up 2.26% to end the trading session at $99.25 as the Company posted its Q1 2014 earnings results. The Company reported a 21.7% YoY rise in Q1 2014 net operating revenues to $4.1 billion. The Company's Q1 2014 net income stood at $660.9 million, or $1.21 per diluted share, compared to net income of $494.7 million, or $0.91 per diluted share, in Q1 2013. The adjusted diluted EPS in the quarter increased to $1.40 from $0.90 in Q1 2013, beating the Reuters' average analysts estimate of $1.20. During Q1 2014, overall total Company production increased 18%, led by a 37% increase in total Company liquids production - crude oil, condensate and natural gas liquids (NGLs). The Company has raised its full-year 2014 crude oil and condensate production growth target to 29% from 27%. The full analyst notes on EOG are available to download free of charge at:

http://www.analystsreview.com/2189-EOG-08May2014.pdf

Anadarko Petroleum Corporation Analyst Notes
On May 5, 2014, Anadarko Petroleum Corporation (Anadarko) released its Q1 2014 earnings results. The Company reported Q1 2014 total revenue of $5.8 billion, up 50.1% YoY. During the quarter, the Company announced a $1.1 billion China divestiture and closed both the $2.64 billion sale of a portion of its interest in Mozambique's Offshore Area 1 and the $581 million Pinedale/Jonah divestiture. During the quarter, the Company also reported contingent loss of $4.3 billion related to Tronox Adversary Proceeding. The Company's Q1 2014 net loss attributable to common stockholders came in at $2.7 billion, or $5.30 diluted loss per share, compared to net income of $460 million, or $0.91 per diluted share, in Q1 2013. The full analyst notes on Anadarko are available to download free of charge at:

http://www.analystsreview.com/2189-APC-08May2014.pdf

Marathon Petroleum Corp. Analyst Notes
On May 1, 2014, Marathon Petroleum Corp. (Marathon) released its Q1 2014 earnings results. The Company reported that Q1 2014 total revenues and other income remained unchanged at $23.3 billion. The Company's Q1 2014 operating income declined 68.8% YoY to $361 million. Quarterly net income attributable to Marathon stood at $199 million, or $0.67 per diluted share, compared to net income of $725 million, or $2.17 per diluted share, in Q1 2013. During the quarter, the Company's cash & cash equivalents declined 5.5% YoY to $2.2 billion. Marathon stated that a number of factors reduced its earnings during the quarter, of which most notable were narrower crude differentials and higher turnaround costs that were partially offset by stronger crack spreads and more favorable net product price realizations. The full analyst notes on Marathon are available to download free of charge at:

http://www.analystsreview.com/2189-MPC-08May2014.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

EDITOR'S NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED